We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,407
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDHL
14001
CALL
Redhill Biopharma
RDHL
$3.53M
$295 ﹤0.01%
23
– –
LAB icon
14002
PUT
Standard BioTools
LAB
$281M
$290 ﹤0.01%
+100
New +$262
ACIU icon
14003
PUT
AC Immune
ACIU
$254M
$285 ﹤0.01%
100
-2,000
-95% -$6.09K
OHAAW
14004
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$284 ﹤0.01%
10,252
-1,528
-13% -$83
DOGZ icon
14005
PUT
Dogness International Corp
DOGZ
$17M
$282 ﹤0.01%
30
-10
-25% -$133
REVBW icon
14006
Revelation Biosciences Warrant
REVBW
$9.12K
$279 ﹤0.01%
16,481
+1,761
+12% +$29
RFACW
14007
DELISTED
RF Acquisition Corp. Warrants
RFACW
$277 ﹤0.01%
11,088
-900
-8% -$15
INTA icon
14008
Intapp
INTA
$3.08B
$268 ﹤0.01%
8
-22,928
-100% -$837K
NUVB icon
14009
PUT
Nuvation Bio
NUVB
$2.18B
$268 ﹤0.01%
+200
New +$333
FRXB.WS
14010
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$268 ﹤0.01%
12,777
+2,186
+21% +$177
CRVS icon
14011
Corvus Pharmaceuticals
CRVS
$1.24B
$267 ﹤0.01%
+183
New +$387
BNCWW
14012
CEA Industries Inc Warrant
BNCWW
$59.3K
$261 ﹤0.01%
13,072
+2,430
+23% +$97
YI
14013
PUT
111 Inc
YI
$33.4M
$260 ﹤0.01%
10
– –
DMAC icon
14014
CALL
DiaMedica Therapeutics
DMAC
$365M
$258 ﹤0.01%
100
-6,900
-99% -$22.2K
SCYX icon
14015
SCYNEXIS
SCYX
$50.3M
$258 ﹤0.01%
+14
New +$334
SOPH icon
14016
CALL
SOPHiA GENETICS
SOPH
$636M
$255 ﹤0.01%
100
– –
SOPH icon
14017
PUT
SOPHiA GENETICS
SOPH
$636M
$255 ﹤0.01%
+100
New +$317
IRIX icon
14018
CALL
IRIDEX
IRIX
$14.9M
$254 ﹤0.01%
+100
New +$190
AGRIW
14019
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$252 ﹤0.01%
12,661
+1,503
+13% +$33
IRIX icon
14020
IRIDEX
IRIX
$14.9M
$251 ﹤0.01%
99
-10,943
-99% -$20.8K
KULR icon
14021
PUT
KULR Technology Group
KULR
$120M
$251 ﹤0.01%
+88
New +$501
ACDCW
14022
DELISTED
ProFrac Holding Corp. Warrant
ACDCW
$250 ﹤0.01%
48,106
+2,945
+7% +$20
APLT
14023
PUT
DELISTED
Applied Therapeutics
APLT
$249 ﹤0.01%
100
-500
-83% -$824
CSSEL
14024
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Warrant
CSSEL
$249 ﹤0.01%
23,226
-2,194
-9% -$34
AQMS icon
14025
Aqua Metals
AQMS
$9.78M
$246 ﹤0.01%
+1
New +$239
559 560
561
562 563

Similar funds

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,407 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.